biotech · Major Depressive Disorder · Schizophrenia · NBIX
NEUROCRINE BIOSCIENCES
NEUROCRINE BIOSCIENCES INC
NEUROCRINE BIOSCIENCES is a biotech organization headquartered in San Diego, USA. It trades on NYSE under ticker NBIX. Primary therapeutic focus areas include Major Depressive Disorder, Schizophrenia, Congenital Adrenal
6027 Edgewood Bend Ct, San Diego, California 92130, US HQ
1992 Founded
2,307 Employees
Public company Type
NBIX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 6027 Edgewood Bend Ct, San Diego, California 92130, US
- Founded
- 1992
- Employees
- 2,307
- Programs
- 79
- Drugs
- 28
- Patents
- 111
NBI-827104
Phase 2 · small molecule · Epileptic Encephalopathy
NBI-827104 for Epileptic Encephalopathy is a Phase 2 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 2 ClinicalTrials.gov record(s).
Internal code NBI-827104-CSWS2025
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- NEUROCRINE BIOSCIENCES INC
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Epileptic Encephalopathy
- Status
- terminated
- Trials
- 2